Cecha
More active than typical
Nazwa kliniczna: Hyperactivity
Hyperactivity is a condition characterized by constant and unusually high levels of activity, even in situations where it is deemed inappropriate.
Podsumowanie
- Znana także jako
- Hyperactive behavior, Hyperactive behaviour, Hyperkinetic disorder
- Układ organizmu
- Abnormality of the nervous system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to More active than typical, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test232 genów powiązanych z More active than typical
Zmiany w tych genach powodują rzadkie choroby, w których występuje More active than typical. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| AASSaminoadipate-semialdehyde synthase | Zawsze | W 2 chorobach |
| AGO1argonaute RISC component 1 | Zawsze | W 1 chorobie |
| AHDC1AT-hook DNA binding motif containing 1 | Zawsze | W 1 chorobie |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Zawsze | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Zawsze | W 1 chorobie |
| AQP4aquaporin 4 | Zawsze | W 1 chorobie |
| ARID1AAT-rich interaction domain 1A | Zawsze | W 2 chorobach |
| ARID2AT-rich interaction domain 2 | Zawsze | W 2 chorobach |
| BBS2Bardet-Biedl syndrome 2 | Zawsze | W 1 chorobie |
| CC2D1Acoiled-coil and C2 domain containing 1A | Zawsze | W 1 chorobie |
| DPYSdihydropyrimidinase | Zawsze | W 1 chorobie |
| FAM177A1family with sequence similarity 177 member A1 | Zawsze | W 1 chorobie |
| GCSHglycine cleavage system protein H | Zawsze | W 1 chorobie |
| GNB5G protein subunit beta 5 | Zawsze | W 1 chorobie |
| GON4Lgon-4 like | Zawsze | W 1 chorobie |
| IGF1insulin like growth factor 1 | Zawsze | W 2 chorobach |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| KDM5Clysine demethylase 5C | Zawsze | W 1 chorobie |
| MANBAmannosidase beta | Zawsze | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 1 chorobie |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Zawsze | W 1 chorobie |
| MID2midline 2 | Zawsze | W 1 chorobie |
| MMADHCmetabolism of cobalamin associated D | Zawsze | W 1 chorobie |
| MSL2MSL complex subunit 2 | Zawsze | W 1 chorobie |
| NSD2nuclear receptor binding SET domain protein 2 | Zawsze | W 1 chorobie |
| PDCD6IPprogrammed cell death 6 interacting protein | Zawsze | W 1 chorobie |
| PNKPpolynucleotide kinase 3'-phosphatase | Zawsze | W 2 chorobach |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Zawsze | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Zawsze | W 1 chorobie |
| SLC6A19solute carrier family 6 member 19 | Zawsze | W 1 chorobie |
| TSHRthyroid stimulating hormone receptor | Zawsze | W 3 chorobach |
| TTI2TELO2 interacting protein 2 | Zawsze | W 2 chorobach |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| UNC13Aunc-13 homolog A | Zawsze | W 2 chorobach |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Bardzo często (80–99%) | W 1 chorobie |
| CUL4Bcullin 4B | Bardzo często (80–99%) | W 2 chorobach |
| MECP2methyl-CpG binding protein 2 | Bardzo często (80–99%) | W 1 chorobie |
| PTCH1patched 1 | Bardzo często (80–99%) | W 1 chorobie |
| AFF2ALF transcription elongation factor 2 | Często (30–79%) | W 2 chorobach |
| ANK3ankyrin 3 | Często (30–79%) | W 2 chorobach |
Pokaż jeszcze 192 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Często (30–79%) | W 1 chorobie |
| AP2M1adaptor related protein complex 2 subunit mu 1 | Często (30–79%) | W 1 chorobie |
| ASH1LASH1 like histone lysine methyltransferase | Często (30–79%) | W 1 chorobie |
| ASPMassembly factor for spindle microtubules | Często (30–79%) | W 1 chorobie |
| ATP1A1ATPase Na+/K+ transporting subunit alpha 1 | Często (30–79%) | W 1 chorobie |
| ATP6V0A1ATPase H+ transporting V0 subunit a1 | Często (30–79%) | W 1 chorobie |
| ATP9AATPase phospholipid transporting 9A | Często (30–79%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Często (30–79%) | W 1 chorobie |
| CHD2chromodomain helicase DNA binding protein 2 | Często (30–79%) | W 2 chorobach |
| CUL3cullin 3 | Często (30–79%) | W 1 chorobie |
| CUX2cut like homeobox 2 | Często (30–79%) | W 1 chorobie |
| DDX3XDEAD-box helicase 3 X-linked | Często (30–79%) | W 2 chorobach |
| DENND5ADENN domain containing 5A | Często (30–79%) | W 1 chorobie |
| DNM1dynamin 1 | Często (30–79%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Często (30–79%) | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Często (30–79%) | W 3 chorobach |
| FBXO11F-box protein 11 | Często (30–79%) | W 1 chorobie |
| FMR1fragile X messenger ribonucleoprotein 1 | Często (30–79%) | W 1 chorobie |
| FRMPD4FERM and PDZ domain containing 4 | Często (30–79%) | W 1 chorobie |
| FZR1fizzy and cell division cycle 20 related 1 | Często (30–79%) | W 1 chorobie |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Często (30–79%) | W 2 chorobach |
| GATAD2BGATA zinc finger domain containing 2B | Często (30–79%) | W 2 chorobach |
| GLRA2glycine receptor alpha 2 | Często (30–79%) | W 1 chorobie |
| GNSglucosamine (N-acetyl)-6-sulfatase | Często (30–79%) | W 1 chorobie |
| HIVEP2HIVEP zinc finger 2 | Często (30–79%) | W 1 chorobie |
| HTThuntingtin | Często (30–79%) | W 1 chorobie |
| IFNGinterferon gamma | Często (30–79%) | W 1 chorobie |
| INPP5Einositol polyphosphate-5-phosphatase E | Często (30–79%) | W 2 chorobach |
| KCNK9potassium two pore domain channel subfamily K member 9 | Często (30–79%) | W 1 chorobie |
| KLHL20kelch like family member 20 | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 2 chorobach |
| LNPKlunapark, ER junction formation factor | Często (30–79%) | W 1 chorobie |
| MAPK10mitogen-activated protein kinase 10 | Często (30–79%) | W 1 chorobie |
| MBD5methyl-CpG binding domain protein 5 | Często (30–79%) | W 1 chorobie |
| NAV3neuron navigator 3 | Często (30–79%) | W 1 chorobie |
| NEXMIFneurite extension and migration factor | Często (30–79%) | W 2 chorobach |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Często (30–79%) | W 2 chorobach |
| NTNG2netrin G2 | Często (30–79%) | W 1 chorobie |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Często (30–79%) | W 2 chorobach |
| OCA2OCA2 melanosomal transmembrane protein | Często (30–79%) | W 1 chorobie |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 2 chorobach |
| PUS7pseudouridine synthase 7 | Często (30–79%) | W 1 chorobie |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 2 chorobach |
| RNU2-2RNA, U2 small nuclear 2 | Często (30–79%) | W 1 chorobie |
| RNU5B-1RNA, U5B small nuclear 1 | Często (30–79%) | W 1 chorobie |
| RUSC2RUN and SH3 domain containing 2 | Często (30–79%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Często (30–79%) | W 2 chorobach |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Często (30–79%) | W 1 chorobie |
| SHROOM4shroom family member 4 | Często (30–79%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Często (30–79%) | W 1 chorobie |
| SLC6A1solute carrier family 6 member 1 | Często (30–79%) | W 1 chorobie |
| SLC6A8solute carrier family 6 member 8 | Często (30–79%) | W 1 chorobie |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Często (30–79%) | W 2 chorobach |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 1 chorobie |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Często (30–79%) | W 1 chorobie |
| THRBthyroid hormone receptor beta | Często (30–79%) | W 1 chorobie |
| TRAPPC9trafficking protein particle complex subunit 9 | Często (30–79%) | W 1 chorobie |
| TSC1TSC complex subunit 1 | Często (30–79%) | W 1 chorobie |
| TSC2TSC complex subunit 2 | Często (30–79%) | W 1 chorobie |
| UBE3Aubiquitin protein ligase E3A | Często (30–79%) | W 3 chorobach |
| UBE3Cubiquitin protein ligase E3C | Często (30–79%) | W 1 chorobie |
| WBP4WW domain binding protein 4 | Często (30–79%) | W 1 chorobie |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Często (30–79%) | W 1 chorobie |
| ZSWIM6zinc finger SWIM-type containing 6 | Często (30–79%) | W 1 chorobie |
| ABCD1ATP binding cassette subfamily D member 1 | Czasami (5–29%) | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Czasami (5–29%) | W 2 chorobach |
| ARID1BAT-rich interaction domain 1B | Czasami (5–29%) | W 1 chorobie |
| ARPC4actin related protein 2/3 complex subunit 4 | Czasami (5–29%) | W 1 chorobie |
| ARXaristaless related homeobox | Czasami (5–29%) | W 1 chorobie |
| ATP10AATPase phospholipid transporting 10A (putative) | Czasami (5–29%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Czasami (5–29%) | W 2 chorobach |
| BAIAP2BAR/IMD domain containing adaptor protein 2 | Czasami (5–29%) | W 1 chorobie |
| BCAP31B cell receptor associated protein 31 | Czasami (5–29%) | W 1 chorobie |
| BCKDKbranched chain keto acid dehydrogenase kinase | Czasami (5–29%) | W 1 chorobie |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Czasami (5–29%) | W 2 chorobach |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Czasami (5–29%) | W 1 chorobie |
| CASKcalcium/calmodulin dependent serine protein kinase | Czasami (5–29%) | W 1 chorobie |
| CDK10cyclin dependent kinase 10 | Czasami (5–29%) | W 1 chorobie |
| CDKL5cyclin dependent kinase like 5 | Czasami (5–29%) | W 1 chorobie |
| CHKAcholine kinase alpha | Czasami (5–29%) | W 1 chorobie |
| CICcapicua transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Czasami (5–29%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Czasami (5–29%) | W 2 chorobach |
| CREBBPCREB binding lysine acetyltransferase | Czasami (5–29%) | W 3 chorobach |
| DMPKDM1 protein kinase | Czasami (5–29%) | W 1 chorobie |
| DMXL2Dmx like 2 | Czasami (5–29%) | W 1 chorobie |
| DPF2double PHD fingers 2 | Czasami (5–29%) | W 2 chorobach |
| DPP6dipeptidyl peptidase like 6 | Czasami (5–29%) | W 1 chorobie |
| DYMdymeclin | Czasami (5–29%) | W 1 chorobie |
| EBPEBP cholestenol delta-isomerase | Czasami (5–29%) | W 2 chorobach |
| FOXP2forkhead box P2 | Czasami (5–29%) | W 1 chorobie |
| GAMTguanidinoacetate N-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| GNAO1G protein subunit alpha o1 | Czasami (5–29%) | W 1 chorobie |
| GRIA1glutamate ionotropic receptor AMPA type subunit 1 | Czasami (5–29%) | W 1 chorobie |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Czasami (5–29%) | W 1 chorobie |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Czasami (5–29%) | W 1 chorobie |
| GRM7glutamate metabotropic receptor 7 | Czasami (5–29%) | W 1 chorobie |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Czasami (5–29%) | W 1 chorobie |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Czasami (5–29%) | W 1 chorobie |
| KDM6Blysine demethylase 6B | Czasami (5–29%) | W 1 chorobie |
| KIF15kinesin family member 15 | Czasami (5–29%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Czasami (5–29%) | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Czasami (5–29%) | W 1 chorobie |
| MICU1mitochondrial calcium uptake 1 | Czasami (5–29%) | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Czasami (5–29%) | W 1 chorobie |
| NEUROD2neuronal differentiation 2 | Czasami (5–29%) | W 1 chorobie |
| NFIXnuclear factor I X | Czasami (5–29%) | W 1 chorobie |
| PAHphenylalanine hydroxylase | Czasami (5–29%) | W 2 chorobach |
| PAK3p21 (RAC1) activated kinase 3 | Czasami (5–29%) | W 1 chorobie |
| PANK2pantothenate kinase 2 | Czasami (5–29%) | W 1 chorobie |
| PCDH19protocadherin 19 | Czasami (5–29%) | W 1 chorobie |
| PIDD1p53-induced death domain protein 1 | Czasami (5–29%) | W 1 chorobie |
| PIGPphosphatidylinositol glycan anchor biosynthesis class P | Czasami (5–29%) | W 1 chorobie |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Czasami (5–29%) | W 1 chorobie |
| PLA2G6phospholipase A2 group VI | Czasami (5–29%) | W 2 chorobach |
| PNPpurine nucleoside phosphorylase | Czasami (5–29%) | W 1 chorobie |
| PPP2R1Aprotein phosphatase 2 scaffold subunit Aalpha | Czasami (5–29%) | W 1 chorobie |
| PUF60poly(U) binding splicing factor 60 | Czasami (5–29%) | W 1 chorobie |
| RAC1Rac family small GTPase 1 | Czasami (5–29%) | W 1 chorobie |
| RHOBTB2Rho related BTB domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Czasami (5–29%) | W 1 chorobie |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Czasami (5–29%) | W 1 chorobie |
| SIK1salt inducible kinase 1 | Czasami (5–29%) | W 1 chorobie |
| SLC1A4solute carrier family 1 member 4 | Czasami (5–29%) | W 2 chorobach |
| SLC25A13solute carrier family 25 member 13 | Czasami (5–29%) | W 1 chorobie |
| SLC25A22solute carrier family 25 member 22 | Czasami (5–29%) | W 1 chorobie |
| SLC32A1solute carrier family 32 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC4A10solute carrier family 4 member 10 | Czasami (5–29%) | W 1 chorobie |
| SLITRK2SLIT and NTRK like family member 2 | Czasami (5–29%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Czasami (5–29%) | W 1 chorobie |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Czasami (5–29%) | W 1 chorobie |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Czasami (5–29%) | W 1 chorobie |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Czasami (5–29%) | W 1 chorobie |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Czasami (5–29%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Czasami (5–29%) | W 1 chorobie |
| SOX11SRY-box transcription factor 11 | Czasami (5–29%) | W 1 chorobie |
| SOX4SRY-box transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| SPRED1sprouty related EVH1 domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| STEEP1STING1 ER exit protein 1 | Czasami (5–29%) | W 1 chorobie |
| STXBP1syntaxin binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| TMEM147transmembrane protein 147 | Czasami (5–29%) | W 1 chorobie |
| TMEM222transmembrane protein 222 | Czasami (5–29%) | W 1 chorobie |
| TRIM8tripartite motif containing 8 | Czasami (5–29%) | W 1 chorobie |
| TRIP12thyroid hormone receptor interactor 12 | Czasami (5–29%) | W 1 chorobie |
| TTI1TELO2 interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| UBTFupstream binding transcription factor | Czasami (5–29%) | W 1 chorobie |
| VPS13Avacuolar protein sorting 13 homolog A | Czasami (5–29%) | W 1 chorobie |
| WDR62WD repeat domain 62 | Czasami (5–29%) | W 1 chorobie |
| YME1L1YME1 like 1 ATPase | Czasami (5–29%) | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Rzadko (1–4%) | W 1 chorobie |
| H3-3AH3.3 histone A | Rzadko (1–4%) | W 1 chorobie |
| HALhistidine ammonia-lyase | Rzadko (1–4%) | W 1 chorobie |
| NKX2-1NK2 homeobox 1 | Rzadko (1–4%) | W 1 chorobie |
| ACY1aminoacylase 1 | Nie odnotowano | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Nie odnotowano | W 1 chorobie |
| ADSLadenylosuccinate lyase | Nie odnotowano | W 1 chorobie |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Nie odnotowano | W 1 chorobie |
| ARG1arginase 1 | Nie odnotowano | W 1 chorobie |
| ATRATR checkpoint kinase | Nie odnotowano | W 1 chorobie |
| ATRXATRX chromatin remodeler | Nie odnotowano | W 1 chorobie |
| CAMTA1calmodulin binding transcription activator 1 | Nie odnotowano | W 1 chorobie |
| CCBE1collagen and calcium binding EGF domains 1 | Nie odnotowano | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Nie odnotowano | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Nie odnotowano | W 1 chorobie |
| DRD4dopamine receptor D4 | Nie odnotowano | W 1 chorobie |
| DRD5dopamine receptor D5 | Nie odnotowano | W 1 chorobie |
| FLCNfolliculin | Nie odnotowano | W 1 chorobie |
| GLDCglycine decarboxylase | Nie odnotowano | W 1 chorobie |
| HDAC4histone deacetylase 4 | Nie odnotowano | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Nie odnotowano | W 1 chorobie |
| HGSNATheparan-alpha-glucosaminide N-acetyltransferase | Nie odnotowano | W 1 chorobie |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Nie odnotowano | W 1 chorobie |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Nie odnotowano | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Nie odnotowano | W 1 chorobie |
| MED12mediator complex subunit 12 | Nie odnotowano | W 1 chorobie |
| NAGLUN-acetyl-alpha-glucosaminidase | Nie odnotowano | W 1 chorobie |
| NBNnibrin | Nie odnotowano | W 1 chorobie |
| OPHN1oligophrenin 1 | Nie odnotowano | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Nie odnotowano | W 1 chorobie |
| PRODHproline dehydrogenase 1 | Nie odnotowano | W 1 chorobie |
| RAB39BRAB39B, member RAS oncogene family | Nie odnotowano | W 1 chorobie |
| SATB2SATB homeobox 2 | Nie odnotowano | W 1 chorobie |
| SGSHN-sulfoglucosamine sulfohydrolase | Nie odnotowano | W 1 chorobie |
| SPRsepiapterin reductase | Nie odnotowano | W 1 chorobie |
| TAF6TATA-box binding protein associated factor 6 | Nie odnotowano | W 1 chorobie |
| TCF20transcription factor 20 | Nie odnotowano | W 1 chorobie |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni